Simona Storti

Simona Storti

Auto-generated profile, based on publicly available information

Simona Storti


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
VLValter Lubrano
Valter Lubrano
Alessandro PingitoreAlessandro Pingitore
Alessandro Pingitore
ITIrene Traghella
Irene Traghella
SSSimona Storti
Simona Storti
.P. Parri
. Parri
Cristina VassalleCristina Vassalle
Cristina Vassalle
Background: Oxidative stress is crucial in the pathogenesis of atherosclerosis and acute myocardial infarction (AMI). Under the generic terms “oxidative stress” (OS), many biomarkers belonging to different pathways have been proposed. Aim: To compare the levels of recently proposed OS-related parameters in acute coronary syndromes (ACS) and stable coronary artery disease (CAD), to evaluate their effectiveness as additive risk or illness indicators of stable and acute ischemic events, and their response over time during the course of AMI. Methods: 76 ACS, 77 CAD patients, and 63 controls were enrolled in the study. Different OS-related biomarkers, including reactive oxygen metabolites (ROM), the total antioxidant capacity (OXY), nitrite/nitrate (final nitric oxide products, NOx), and Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), were evaluated. Moreover, time response during AMI course (admission, and 6, 12, 18, 24, 36, and 48 hours after, T0-T6, respectively) and correlation with traditional cardiovascular (CV) risk factors (age, gender, hypertension, diabetes mellitus, dyslipidemia, smoking habit) were also assessed. Results: Over time, ROM progressively increased while OXY and NOx decreased. Kinetics of LOX-1 during AMI shows that this biomarker boosts early during the acute event (T1 and T2) and then progressively decreases, being significantly lower from T0 to T6. Different OS-related biomarkers were differentially associated with CV risk factors and CAD or ACS presence. Conclusion: Differences in OS-related biomarkers (between groups, according to the response over time during AMI, and to the presence of CV risk factors) confirmed OS involvement in the transition from healthy status to stable CAD and ACS, although evidencing the heterogeneous nature of redox processes. In future, a multi-marker panel including different biomarkers and pathways of oxidative stress could be evaluated as an additive tool to be used in the CV prevention, diagnosis, patient stratification, and treatment.

9 October 2021 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
AAAlberto Aimo
Alberto Aimo
SCSara Chiappino
Sara Chiappino
ACAlberto Clemente
Alberto Clemente
DLDaniele Della Latta
Daniele Della Latta
NMNicola Martini
Nicola Martini
DNDanilo Neglia
Danilo Neglia

7 May 2021 in Clinical Journal of Sport Medicine
Verified
Journal Article
Closed access
Massimiliano CantinottiMassimiliano Cantinotti
Massimiliano Cantinotti
ACAldo Clerico
Aldo Clerico
Raffaele GiordanoRaffaele Giordano
Raffaele Giordano
NANadia Assanta
Nadia Assanta
EFEliana Franchi
Eliana Franchi
Flavio D'AscenziFlavio D'Ascenzi
Flavio D'Ascenzi
Background: Postexercise release of cardiac troponin (cTn) is a well-known phenomenon, although the influence of various confounders remains unclear. The aim of this critical review was to analyze the postexercise release of cTn according to age, sex, different types of sport, exercise intensity and duration, and training level. Data Sources: A literature search was performed within the National Library of Medicine using the following keywords: cTn, peak, release, and exercise. The search was further refined by adding the keywords athletes, children/adolescents, and sport. Main Results: For final analysis, 52 studies were included: 43 adult studies, 4 pediatric studies, and 5 with a mixed population of adults and children. Several studies have investigated the kinetics of cTn response after exercise with different biomarkers. The current evidence suggests that sport intensity and duration have significant effects on postexercise cTn elevation, whereas the influence of the type of sport, age, and sex have been not completely defined yet. Most data were obtained during endurance races, whereas evidence is limited (or almost absent), particularly for mixed sports. Data on young adults and professional athletes are limited. Finally, studies on women are extremely limited, and those for non-White are absent. Conclusions: Postexercise release of cTn can be observed both in young and master athletes and usually represents a physiological phenomenon; however, more rarely, it may unmask a subclinical cardiac disease. The influence of different confounders (age, sex, sport type/intensity/duration, and training level) should be better clarified to establish individualized ranges of normality for postexercise cTn elevation.

19 January 2018 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
PDF file
SMSilvia Masotti
Silvia Masotti
VMVeronica Musetti
Veronica Musetti
CPConcetta Prontera
Concetta Prontera
SSSimona Storti
Simona Storti
CPClaudio PASSINO
Claudio PASSINO
ACAldo Clerico
Aldo Clerico

1 December 2015 in Clinica Chimica Acta
Verified
Journal Article
Open access
SSSimona Storti
Simona Storti
SMSilvia Masotti
Silvia Masotti
CPConcetta Prontera
Concetta Prontera
MFMaria Franzini
Maria Franzini
PBPaola Buzzi
Paola Buzzi
ACAldo Clerico
Aldo Clerico
The study aims are to evaluate the analytical performance and the clinical results of the chemiluminescent Access AccuTnI + 3 immunoassay for the determination of cardiac troponin I (cTnI) with DxI 800 and Access2 platforms and to compare the clinical results obtained with this method with those of three cTnI immunoassays, recently introduced in the European market. The limits of blank (LoB), detection (LoD), and quantitation (LoQ) at 20% CV and 10% CV were 4.5 ng/L and 10.9 ng/L, 17.1 and 30.4 ng/L, respectively. The results of STAT Architect high Sensitive TnI (Abbott Diagnostics), ADVIA Centaur Troponin I Ultra (Siemens Healthcare Diagnostics), ST AIA-Pack cTnI third generation (Tosoh Bioscience), and Access AccuTnI + 3 (Beckman Coulter Diagnostics) showed very close correlations (R ranging from 0.901 to 0.994) in 122 samples of patients admitted to the emergency department. However, on average there was a difference up to 2.4-fold between the method measuring the highest (ADVIA method) and lowest cTnI values (AccuTnI + 3 method). The consensus mean values between methods ranged from 6.2% to 29.6% in 18 quality control samples distributed in an external quality control study (cTnI concentrations ranging from 29.3 ng/L to 1557.5 ng/L). In conclusion, the results of our analytical evaluation concerning the AccuTnI + 3 method, using the DxI platform, are well in agreement with those suggested by the manufacturer as well as those reported by some recent studies using the Access2 platform. Our results confirm that the AccuTnI + 3 method for the Access2 and DxI 800 platforms is a clinically usable method for cTnI measurement.

1 October 2004 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
SSSimona Storti
Simona Storti
ACAlfredo Giuseppe Cerillo
Alfredo Giuseppe Cerillo
ARAntonio Rizza
Antonio Rizza
IGIsabella Giannelli
Isabella Giannelli
GFGiuliana Fontani
Giuliana Fontani
ACAldo Clerico
Aldo Clerico
Objective: It has been suggested that cardiac surgery-related ischemia-reperfusion injury to the myocardium is caused by the oxidative stress, derived from the formation of reactive oxygen species in the early phases of the reperfusion. The availability of cysteine, mostly deriving from homocysteine (Hcy) via the trans-sulfuration pathway, is determinant for the synthesis of glutathione (GSH), which in turn acts as a first line of defence against oxidative stress. Indeed, an increased consumption of Hcy in response to oxidative stress has been described. Previous research has shown that Hcy levels increase during the first weeks or months after coronary artery bypass grafting (CABG). This study was designed to evaluate the Hcy metabolism in CABG patients during the early postoperative period. Methods: Serum Hcy and folate were measured by an automatic immunometric system on blood samples obtained from 48 (mean age 67±10 years) consecutive patients undergoing CABG, preoperatively and at 0, 12, 48, and 120 h after surgery. A subgroup of 22 of these patients was also studied 6 months postoperatively. Results: A significant decrement of Hcy and folate was observed throughout the study (P≪0.0001) from 17.3±9.3 to 8.5±5.6 μmol/l at 12 h postoperatively for Hcy, and from 5.1±2.8 to 2.5±1.5 ng/ml at 48 h for folate. The reduction of Hcy and folate levels remained significant after correction for haemodilution (as assessed by measurement of plasma proteins). Furthermore, the use of cardiopulmonary bypass significantly interacted with the time of sampling in affecting the Hcy levels. Hcy levels returned to near-baseline values 48 h postoperatively, and were similar to base-line at follow-up. Conclusion: Our study indicates that serum Hcy and folate levels are markedly reduced during the early postoperative period after CABG. This reduction is at least in part independent of haemodilution, and may be caused by an altered Hcy turnover, due to an increased consumption of GSH during and soon after CABG.